SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
76.68    1.88 (2.51%)
Bid:
76.38
Ask:
76.50
Spread: 0.12 (0.157%)
Market Cap: £2.66b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

Director/PDMR Shareholding

11 May 2016 15:14

RNS Number : 9726X
Taylor Wimpey PLC
11 May 2016
Β 

Β 

Annex DTR3

Β 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

Β 

Β 

All relevant boxes should be completed in block capital letters.

Β 

1.

Name of the issuer

Β 

Β 

TAYLOR WIMPEY PLC

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

(ii) a disclosure made in accordance

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

NOTIFICATION IN ACCORDANCE WITH DTR3.1.2R

3.

Name of person discharging managerial

responsibilities/director

Β 

PETER REDFERN

(DIRECTOR)

Β 

JAMES JORDAN

(DIRECTOR)

Β 

RYAN MANGOLD

(DIRECTOR)

4.

State whether notification relates to a person

connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

Β 

NOTIFICATION RELATES DIRECTLY TO THE DIRECTORS NAMED IN 3.

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non beneficial

interest 1

NOTIFICATION RELATES TO THE HOLDING OF THE DIRECTORS LISTED ABOVE

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Β 

ORDINARY SHARES OF 1P EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

PETER REDFERN

OWN NAME

3,312,654 SHARES

EQUINITI SHARE PLAN TRUSTEES LIMITED 18,954 SHARES

Β 

JAMES JORDAN:

OWN NAME

1,529,622 SHARES

EQUINITI SHARE PLAN TRUSTEES LIMITED 45,318 SHARES

Β 

RYAN MANGOLD

914,485 SHARES

EQUINITI SHARE PLAN TRUSTEES LIMITED 39,298 SHARES

Β 

8.

State the nature of the transaction

Β 

Β 

Β 

SHARES ACQUIRED PURSUANT TO PARTICIPATION IN THE COMPANY'S SHARE PURCHASE PLAN ("SIP") AND THE FREE ONE FOR ONE MATCHING AWARD OF AN EQUIVALENT NUMBER OF SHARES BY THE COMPANY

9.

Number of shares, debentures or financial

instruments relating to shares acquired

Β 

PETER REDFERN

83 SHARES ACQUIRED AT 181.6 PENCE EACH AND 83 SHARES MATCHED FREE BY THE COMPANY.

Β 

JAMES JORDAN

83 SHARES ACQUIRED AT 181.6 PENCE EACH AND 83 SHARES MATCHED FREE BY THE COMPANY.

Β 

RYAN MANGOLD

991 SHARES ACQUIRED AT 181.6 PENCEAND 991 SHARES MATCHED FREE BY THE COMPANY.

Β 

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

Β 

0.000005%

Β 

Β 

Β 

Β 

0.000005%

Β 

Β 

Β 

Β 

0.00006%

11.

Number of shares, debentures or financial

instruments relating to shares disposed

Β 

N/A

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

Β 

N/A

Β 

13.

Price per share or value of transaction

Β 

181.6 PENCE

Β 

14.

Date and place of transaction

Β 

Β Β 9th MAY 2016; LONDON

Β 

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

Β 

PETER REDFERN 3,331,774 (0.10%)

Β 

JAMES JORDAN 1,575,106 (0.048%)

Β 

RYAN MANGOLD 955,765 (0.029%)

Β 

Β 

16.

Date issuer informed of transaction

Β 

Β 

Β 

Β 10TH MAY 2016

Β 

If a person discharging managerial responsibilities has been granted options by the issuer

complete the following boxes

Β 

17.

Date of grant

Β 

Β 

18.

Period during which or date on which exercisable

Β 

Β 

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

Β 

Β 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise

Β 

22.

Total number of shares or debentures over which options held following notification

Β 

Β 

Β 

Β 

23.

Any additional information

Β 

24.

Name of contact and telephone number for queries

COLIN CLAPHAM 01494 885612

Β 

Β 

Β 

Name of authorised official of issuer responsible for making notification

Β 

COLIN CLAPHAM - ASSISTANT SECRETARY

Β 

Date of notification 11TH MAY 2016

Β 

Β 

Β 

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

Β 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHSFEFLFFMSEFI
Date   Source Headline
12th Jun 20267:00 amRNSDirector/PDMR Shareholding
9th Jun 20263:11 pmRNSDirector/PDMR Shareholding
9th Jun 20267:00 amRNSDirectorate change
1st Jun 20267:00 amRNSTotal Voting Rights
20th May 202610:41 amRNSHolding(s) in Company
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20269:49 amRNSDirector/PDMR Shareholding
15th May 20261:32 pmRNSHolding(s) in Company
14th May 20267:00 amRNSTransaction in Own Shares
11th May 20264:10 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20263:30 pmRNSHolding(s) in Company
6th May 202611:05 amRNSHolding(s) in Company
5th May 202611:28 amRNSHolding(s) in Company
1st May 202611:53 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20264:34 pmRNSDirector/PDMR Shareholding
28th Apr 20264:23 pmRNSResult of AGM
28th Apr 20267:00 amRNSTrading Statement
23rd Apr 20269:25 amRNSTransaction in Own Shares
20th Apr 20268:41 amRNSDirector Declaration
16th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20263:42 pmRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20261:36 pmRNSTotal Voting Rights
30th Mar 20262:19 pmRNSHolding(s) in Company
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20263:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20262:22 pmRNSHolding(s) in Company
20th Mar 20263:37 pmRNSAnnual Financial Report and Notice of Meeting
19th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20263:23 pmRNSDirector/PDMR Shareholding
10th Mar 20263:23 pmRNSDirector/PDMR Shareholding
6th Mar 202611:44 amRNSDirector/PDMR Shareholding
5th Mar 20267:01 amRNSShare Buyback Programme
5th Mar 20267:00 amRNSTAYLOR WIMPEY PLC FULL YEAR RESULTS
2nd Mar 202611:50 amRNSTotal Voting Rights
10th Feb 20263:19 pmRNSDirector/PDMR Shareholding
2nd Feb 20262:17 pmRNSTotal Voting Rights
22nd Jan 20263:11 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSTrading Statement
9th Jan 20262:51 pmRNSDirector/PDMR Shareholding
2nd Jan 202612:02 pmRNSTotal Voting Rights
2nd Jan 202611:59 amRNSBlock listing Interim Review
2nd Jan 202611:54 amRNSBlock listing Interim Review
15th Dec 20254:17 pmRNSDirector/PDMR Shareholding
9th Dec 20254:21 pmRNSDirector/PDMR Shareholding
9th Dec 20254:18 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.